BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP AND Prognosis
19 results:

  • 1. USP46 enhances tamoxifen resistance in breast cancer cells by stabilizing PTBP1 to facilitate glycolysis.
    Gao S; Wang Y; Xu Y; Liu L; Liu S
    Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167011. PubMed ID: 38176460
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. NAA20 recruits Rin2 and promotes triple-negative breast cancer progression by regulating Rab5A-mediated activation of EGFR signaling.
    Qiao L; Dong C; Jia W; Ma B
    Cell Signal; 2023 Dec; 112():110922. PubMed ID: 37827343
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Curcumin induces mitophagy by promoting mitochondrial succinate dehydrogenase activity and sensitizes human papillary thyroid carcinoma BCPAP cells to radioiodine treatment.
    Zhang L; Qiu L; Xu S; Cheng X; Wu J; Wang Y; Gao W; Bao J; Yu H
    Toxicol In Vitro; 2023 Dec; 93():105669. PubMed ID: 37634662
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. GSG2 facilitates the progression of human breast cancer through MDM2-mediated ubiquitination of E2F1.
    Tang Y; Dai G; Yang Y; Liu H
    J Transl Med; 2023 Aug; 21(1):523. PubMed ID: 37537694
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Analyzing County-level Social Vulnerabilities of Head and Neck Melanomas in the United States.
    McCampbell L; Fei-Zhang DJ; Chelius D; Rastatter J; Sheyn A
    Laryngoscope; 2024 Jan; 134(1):185-190. PubMed ID: 37341511
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Papillary thyroid cancer immune phenotypes via tumor-infiltrating lymphocyte spatial analysis.
    Nam M; Yang W; Kim HS; Park J; Park G; Kim S; Song S; Ock CY; Wang VG; Chuang JH; Chae YK
    Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 37279258
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway.
    Feng Z; Ke S; Wang C; Lu S; Xu Y; Yu H; Li Z; Yin B; Li X; Hua Y; Qian B; Bai M; Fu Y; Zhang Y; Wu Y; Ma Y
    Oncogene; 2023 Jun; 42(24):2017-2030. PubMed ID: 37142680
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. CircRNF10-DHX15 interaction suppressed breast cancer progression by antagonizing DHX15-NF-κB p65 positive feedback loop.
    Zheng W; Wang X; Yu Y; Ji C; Fang L
    Cell Mol Biol Lett; 2023 Apr; 28(1):34. PubMed ID: 37101128
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. ACAT1-mediated METTL3 acetylation inhibits cell migration and invasion in triple negative breast cancer.
    Zhang G; Huang R; Zhao H; Xia Y; Huang H; Qian M; Fu Y; Cui Y
    Genes Immun; 2023 Apr; 24(2):99-107. PubMed ID: 36890220
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. TRIB3 Interacts with STAT3 to Promote cancer Angiogenesis.
    Chen QZ; Chen Y; Li X; Liu H; Sun XL
    Curr Med Sci; 2022 Oct; 42(5):932-940. PubMed ID: 36245025
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Endocrine and neuroendocrine tumors].
    Riss P; Scheuba K; Strobel O
    Chirurg; 2021 Nov; 92(11):996-1002. PubMed ID: 34618164
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. BGL3 inhibits papillary thyroid carcinoma progression via regulating PTEN stability.
    Zhao M; Yang F; Sang C; Yan C; Wang Z
    J Endocrinol Invest; 2021 Oct; 44(10):2165-2174. PubMed ID: 33543443
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. SUMOylation of HSP27 regulates PKM2 to promote esophageal squamous cell carcinoma progression.
    Zhang X; Liu T; Zheng S; Liu Q; Shen T; Han X; Zhang Q; Yang L; Lu X
    Oncol Rep; 2020 Oct; 44(4):1355-1364. PubMed ID: 32945483
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Significant association of PKM2 and NQO1 proteins with poor prognosis in breast cancer.
    Zhu K; Li Y; Deng C; Wang Y; Piao J; Lin Z; Chen L
    Pathol Res Pract; 2020 Nov; 216(11):153173. PubMed ID: 32841776
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. DUOX2 promotes the progression of colorectal cancer cells by regulating the AKT pathway and interacting with RPL3.
    Zhang X; Han J; Feng L; Zhi L; Jiang D; Yu B; Zhang Z; Gao B; Zhang C; Li M; Zhao L; Wang G
    Carcinogenesis; 2021 Feb; 42(1):105-117. PubMed ID: 32531052
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. TRIM30 modulates Interleukin-22-regulated papillary thyroid cancer cell migration and invasion by targeting Sox17 for K48-linked Polyubiquitination.
    Li W; Li F; Lei W; Tao Z
    Cell Commun Signal; 2019 Dec; 17(1):162. PubMed ID: 31823782
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Malignant head/neck paragangliomas. Comparative study.
    Mediouni A; Ammari S; Wassef M; Gimenez-Roqueplo AP; Laredo JD; Duet M; Tran Ba Huy P; Oker N
    Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Jun; 131(3):159-66. PubMed ID: 24239180
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Hereditary paragangliomas.
    Raygada M; Pasini B; Stratakis CA
    Adv Otorhinolaryngol; 2011; 70():99-106. PubMed ID: 21358191
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Molecular analysis of multifocal papillary thyroid carcinoma.
    Lin X; Finkelstein SD; Zhu B; Silverman JF
    J Mol Endocrinol; 2008 Oct; 41(4):195-203. PubMed ID: 18628356
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.